QT
VKTX icon

Quantamental Technologies’s Viking Therapeutics VKTX Stock Holding History

Quantamental Technologies’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,015
Closed -$167K – 658
2023
Q1 		$167K Sell
10,015
-38,266
-79% -$395K 0.09% 359
2022
Q4 		$454K Buy
+48,281
New +$216K 0.21% 182
2019
Q4 		– Sell
-8,725
Closed -$60K – 1316
2019
Q3 		$60K Buy
8,725
+2,700
+45% +$20.1K 0.02% 911
2019
Q2 		$50K Buy
+6,025
New +$51.5K 0.02% 898

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Quantamental Technologies's VKTX Position: Q2 2023 in Review

Quantamental Technologies sold out of Viking Therapeutics (VKTX) in Q2 2023, closing a stake of 10,015 shares — an estimated $167K sold.

Quantamental Technologies first reported a position in VKTX in Q2 2019 and held it in 4 quarters. The position peaked at $454K in Q4 2022. 193 funds tracked by Wall St. Rank hold VKTX as of Q2 2023.

  • Quantamental Technologies reported no remaining Viking Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 10,015 Viking Therapeutics shares in Q2 2023, an estimated $167K.
  • Quantamental Technologies first reported a position in Viking Therapeutics in Q2 2019 and held it in 4 quarters.
  • Quantamental Technologies's Viking Therapeutics position peaked at $454K in Q4 2022.
  • 193 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.